MLDA had participated in the World Orphan Drug Congress Asia 2013 which has held in Singapore recently.

World Orphan Drug Congress Asia 2013 is Asia’s most strategic orphan drug industry event. This event is dedicated to fostering partnerships and collaboration amongst industry, governments, and patients.
Bringing together more than 150 orphan drugs stakeholders, this event will focus on expediting orphan drug development and articulating its value, from discovery to clinical development, to licensure, to manufacturing, to launch, and to sustainability
of supply, so that manufacturers are guaranteed full and speedy reimbursements. This event will also cover a range of topics that are pertaining to market access and patient care.